Unibest
← Back to patent-cliff list

CAS 102096-25-3

2,2,2-Trifluoroethyl 2-methylpropanoate2,2,2-trifluoroethyl isobutyrate

Codes: Molnupiravir-042, LONA-022

Application context (from source-drug indications)

COVID-19Molnupiravir呼吸道合胞体病毒感染MolnupiravirInfluenza virus infectionMolnupiravirRenal impairmentMolnupiravirHepatic function declineMolnupiravir早衰综合征Lonafarnib丁型肝炎Lonafarnib幕上肿瘤Lonafarnib神经胶质肉瘤Lonafarnib慢性丁型肝炎LonafarnibNon-small cell lung cancerLonafarnib

Source drugs (routes using this intermediate)

DrugTierExpiry
MolnupiravirTier B — Position early-
LonafarnibTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

MolnupiravirOptimised routesteps: 7total yield: 30.72g(Molnupiravir)
LonafarnibOptimised routesteps: 3total yield: /

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Unibest Taizhou GMP-like Site((3aR,4R,6R,6aR)-6-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.